— Know what they know.
Not Investment Advice

LNTH NASDAQ

Lantheus Holdings, Inc.
1W: +0.2% 1M: -0.8% 3M: -2.8% YTD: +48.6% 1Y: +93.6% 3Y: +51.7% 5Y: +270.6%
$99.96
+0.31 (+0.31%)
 
Weekly Expected Move ±0.5%
$99 $99 $100 $101 $101
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 41 · $6.5B mcap · 58M float · 2.17% daily turnover · Short 48% of daily vol

📊 Key Metrics

TTM
$2B
Revenue
+2.3% YoY
$275M
Net Income
+1.6% YoY
$510M
Free Cash Flow
+8.3% YoY
62.3%
Gross Margin
25.8%
Op. Margin
19.3%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE22.2%
ROA12.2%
ROIC17.1%

Valuation

P/E23.7
P/B5.0
EV/EBITDA16.2

Leverage

Debt/Equity0.48
Current Ratio3.06
Interest Cov.19.3x

Quality Scores

Piotroski F5/9
Altman Z6.09
Beneish M-2.71

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms